Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With Benralizumab.
Saved in:
| Title: | Overcoming Barriers to Remission in Severe Eosinophilic Asthma: Two-Year Real-World Data With Benralizumab. |
|---|---|
| Authors: | Jackson DJ; Guy's Severe Asthma Centre, Guy's & St Thomas' NHS Trust, London, UK.; School of Immunology & Microbial Sciences, King's College London, London, UK., Burhan H; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.; University of Liverpool, Liverpool, UK., Rupani H; University Hospital Southampton NHS Foundation Trust, Southampton, UK., Pfeffer PE; St. Bartholomew's Hospital, London, UK., Clifton IJ; University of Leeds, Leeds, UK., Faruqi S; Hull University Teaching Hospitals, Hull, UK., Dhariwal J; Guy's Severe Asthma Centre, Guy's & St Thomas' NHS Trust, London, UK., Patel P; Royal Brompton and Harefield Hospitals, London, UK., Morris T; AstraZeneca UK, London, UK., Lipworth J; AstraZeneca UK, London, UK., Watt M; AstraZeneca UK, London, UK., Lupton C; AstraZeneca UK, London, UK., Dube S; AstraZeneca UK, London, UK., Hickey J; OPEN Health, Marlow, UK., Nanzer AM; Guy's Severe Asthma Centre, Guy's & St Thomas' NHS Trust, London, UK.; School of Immunology & Microbial Sciences, King's College London, London, UK. |
| Source: | Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2024 Oct; Vol. 54 (10), pp. 734-746. Date of Electronic Publication: 2024 Jul 31. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 8906443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2222 (Electronic) Linking ISSN: 09547894 NLM ISO Abbreviation: Clin Exp Allergy Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2222 |
|---|---|
| DOI: | 10.1111/cea.14544 |
